? Efficacy data is due early 2022. Why is everyone posting like the sky is calling in here. I really hope people are doing their own research and not selling based on the hyperbole posted on here over theist day or so.
- Forums
- ASX - By Stock
- 1AD
- Ann: AD-214 pathway to IPF efficacy studies
1AD
adalta limited
Add to My Watchlist
0.00%
!
0.2¢

Ann: AD-214 pathway to IPF efficacy studies, page-57
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $3.704K | 1.851M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 19990238 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 6130560 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 19990238 | 0.002 |
16 | 42053497 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 6130560 | 15 |
0.004 | 13062108 | 11 |
0.005 | 2946002 | 7 |
0.006 | 1963830 | 1 |
0.007 | 133335 | 1 |
Last trade - 14.58pm 23/06/2025 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |